Beijing-based biopharmaceutical company developing recombinant protein and peptide medicines, with a focus on chronic metabolic and age-related diseases
Beijing-based biopharmaceutical company developing recombinant protein and peptide medicines, with a focus on chronic metabolic and age-related diseases. Its pipeline includes long-acting, oral and multi-target therapies, including a monthly GLP-1 receptor agonist for weight loss. The company also develops biosimilars and operates a recombinant-protein drug development platform.